Corrigendum: Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency

• Bob Geng,
• Kim Clark,
• Mark Evangelista,
• Eric Wolford

Affiliations

Bob Geng

Division of Allergy & Immunology, University of California, San Diego, CA, United States

Kim Clark

Global Medical Department, Bio Products Laboratory, Ltd., Elstree, United Kingdom

Mark Evangelista

Biostatistics Department, Atlantic Research Group, Charlottesville, VA, United States

Eric Wolford

Global Medical Department, Bio Products Laboratory, Ltd., Elstree, United Kingdom